CYCN SCHEDULE 13G: SEC filing

Janus Henderson Group Ltd.

Filed with the SEC on · accession 0001274173-26-000284

CYCN filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Janus Henderson Group Ltd. filed a Schedule 13G reporting beneficial ownership of 2,344,819 shares (5.2%) of Korsana Biosciences, Inc. common stock as of September 30, 2026, held through its asset manager subsidiaries on behalf of managed portfolios.

Key details

Shares beneficially owned$2.3M
Percent of class beneficially owned$5
Filer / beneficial ownerJanus Henderson Group Ltd.
IssuerKorsana Biosciences, Inc.
Head of north america compliance, janus henderson group ltd.Kristin Mariani

✦ Ask GOAX AI about this filing — what it means for CYCN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CYCN?

Click here

Frequently asked questions

What did CYCN file with the SEC on Nov 16, 2026?

CYCN filed a SCHEDULE 13G (SEC filing). Janus Henderson Group Ltd. filed a Schedule 13G reporting beneficial ownership of 2,344,819 shares (5.2%) of Korsana Biosciences, Inc. common stock as of September 30, 2026, held through its asset manager subsidiaries on behalf of managed portfolios.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other CYCN SEC filings

Get alerts when CYCN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days